Organization

Advocate Aurora Health, Milwaukee, WI

2 abstracts

Abstract
Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study.
Org: CRO Aviano National Cancer Institute, IRCCS, Aviano, Italy, Dana-Farber Cancer Institute, Boston, MA, USA, Weill Cornell Medicine, New York, NY, Miami Cancer Institute, Baptist Health South Florida, Plantation, FL, Washington University School of Medicine, St. Louis, MO,